Skip to main content
SpringerLink
Log in

Neuroendokrine Tumoren des Pankreas

Diagnostik und Therapie von funktionellen und nichtfunktionellen neuroendokrinen Neoplasien

  • Gastroonkologie
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© F. Scheufele, H. Friess

Literatur

  1. Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol. 2007;20 Suppl 1:94-112

  2. Hallet J et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121(4):589-97

  3. Dasari A et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3(10):1335-42

  4. Fesinmeyer MD et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1766-73

  5. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135(5):1469-92

  6. Leoncini E et al. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016;27(1):68-81

  7. Capurso G et al. Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. Am J Gastroenterol. 2009;104(12):3034-41

  8. de Mestier L et al. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study. Ann Intern Med. 2015;162(10):682-9

  9. Service FJ et al. Functioning Insulinoma—Incidence, Recurrence, and Long-Term Survival of Patients: A 60-Year Study. Mayo Clinic Proceedings. 1991;66(7):711-19

  10. Harrington MG et al. A Prospective Survey for Insulinomas in a Neurology Department. The Lancet. 1983;321(8333):1094-95

  11. Placzkowski KA et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009;94(4):1069-73

  12. Brennan MD et al. Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis. The American Journal of Medicine. 1980;68(6):941-8

  13. Norton JA et al. Gastrinomas: Medical or Surgical Treatment. Endocrinol Metab Clin North Am. 2018;47(3):577-601

  14. Roy PK et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2000;79(6):379-411

  15. Metz DC et al. Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing. Int J Endocr Oncol. 2017;4(4):167-85

  16. Meko JB, Norton JA. Management of patients with Zollinger-Ellison syndrome. Annu Rev Med. 1995;46:395-411

  17. Song X et al. Glucagonoma and the glucagonoma syndrome. Oncol Lett. 2018;15(3):2749-55

  18. Wermers RA et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore). 1996;75(2):53-63

  19. Boden G. Glucagonomas and insulinomas. Gastroenterol Clin North Am, 1989;18(4):831-45

  20. Krejs GJ. VIPoma syndrome. Am J Med. 1987;82(5B):37-48

  21. Vagefi PA et al. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg. 2007;142(4):347-54

  22. Li J et al. Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumors. Med Oncol. 2011;28(4):1027-31

  23. Nomura N et al. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management. J Hepatobiliary Pancreat Surg. 2009;16(5):639-47

  24. Cheema A et al. Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes. Ann Surg Oncol. 2012;19(9):2932-6

  25. Riihimaki M et al. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139(12):2679-86

  26. Paulson EK et al. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology. 1998;206(1):143-50

  27. Legmann P et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998;170(5):1315-22

  28. Thoeni RF et al. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214(2):483-90

  29. Dromain C et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography and magnetic resonance imaging. J Clin Oncol. 2005;23(1):70-8

  30. Pisegna JR et al. Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci. 1993;38(7):1318-28

  31. James PD et al. Incremental benefit of preoperative EUS for the detection of pancreatic neuroendocrine tumors: a meta-analysis. Gastrointest Endosc. 2015;81(4):848-56 e1

  32. Kulke MH et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39(6):735-52

  33. Partelli S et al. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg. 2017;104(1):34-41

  34. Birnbaum DJ et al. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study. Ann Surg Oncol. 2015;22(3):1000-7

  35. Norton JA et al. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg. 2003;138(8):859-66

  36. Demeure MJ et al. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery. 1991;110(6):998-1004; discussion 1004-5

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Chirurgie, Klinikum rechts d. Isar der TU München, Ismaninger Str. 22, 81675, München, Deutschland

    Florian Scheufele

  2. Klinik und Poliklinik für Chirurgie, Klinikum rechts der Isar der TU München, Ismaninger Str. 22, 81675, München, Deutschland

    Helmut Friess (Direktor der Klinik und Poliklinik für Chirurgie)

Authors
  1. Florian Scheufele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helmut Friess
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scheufele, F., Friess, H. Neuroendokrine Tumoren des Pankreas. Im Fokus Onkologie 26, 14–19 (2023). https://doi.org/10.1007/s15015-022-3030-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-022-3030-0

Search

Navigation